Form 0920-22FZ Att 4f_Patient Interiew Guide English

Form Approved

OMB No. 0920-New

Expiration Date: XX/XX/XXXX

mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Provider Training and Adherence Assistance in Two High Priority Settings

Attachment 4f

Patient Interview Guide English

Public reporting burden of this collection of information is estimated to average 90 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-New)

Protocol: AAAT8812

Study: mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings

mChoice Study and CleverCap App Follow-up Interview Guide:

INTRODUCTION: This interview is to help us understand your thoughts about your participation in the mChoice study and using the CleverCap app and CleverCap pill bottle [only if participant is/was on oral PrEP]. I’ll be asking you open-ended interview questions. There are no right or wrong answers. The interview will last about 1 hour and will be recorded. We will make every effort to protect your privacy and confidentiality by keeping your responses confidential and not recording any of your identifiable information. Before we start, please remember that your participation is voluntary, meaning that you do not have to answer any question that makes you uncomfortable, and you may stop at any time.

In the following questions, I will be asking you about your experience with the mChoice study. When I say mChoice study, I mean the 6 study visits you completed at [site] and your use of the CleverCap app and CleverCap pill bottle. Do you have any questions before we begin?

1. How was the mChoice study helpful to you when choosing a PrEP regimen?

• Did you feel you were given enough information to choose a PrEP regimen?

• Were the in-person discussions during the study visits helpful?

• Did you find it easy to have a conversation with your provider about different PrEP regimens?

• Did you use the CleverCap app to learn about different PrEP options?

2. How helpful was the mChoice study for improving your understanding of PrEP?

• Did you know about PrEP’s ability to prevent HIV prior to starting the mChoice study?

• Did you know about the different PrEP options prior to starting the mChoice study?

• Did you know how to maintain your PrEP regimen prior to starting the mChoice study?

• Did you know about the importance of adhering to your PrEP regimen?

3. How helpful was the mChoice study for improving your overall communication with your provider?

• How comfortable did you feel talking honestly with your provider about your sexual activities? Drug use activities?

• Did you feel like your provider listened to you? Why or why not?

4. What would you change or improve about the mChoice study altogether? What would you change or improve about the app?

5. Did you change your PrEP regimen during the study? Why or why not?

• If yes, were you happy with the change?

• If yes, did you change more than once?

• If yes, was your provider supportive of your change?

• If yes, was the app more helpful/useful for one regimen versus another?

• If no, were you happy with the original PrEP regimen that you were originally prescribed?

• If no, did you stop using PrEP at any point?

6. How often did you use the app in a typical week?

• What were your most common reasons for using the app?

• Were you comfortable with using the app in social settings?

• If you are/were taking oral PrEP, did you use your CleverCap device? Was the CleverCap device easy to use? Why or why not?

7. Would you recommend the CleverCap app to a friend?

• Is there anything you wish was different about the app? Is there anything that would make it more useful?

• Describe the usefulness of the reminders to take your medication and attend the clinic appointments with your provider.

• If you were on oral PrEP, describe the usefulness of the CleverCap pill bottle.

8. Did you stop using the app altogether at some point? (If yes: Why?)

9. Would you continue to use the app and pill bottle after the study if you could? Why or why not?

10. Did you find participation in the mChoice study to be valuable?

11. Do you think that going forward, it will be easier to have conversations with your provider about PrEP?

12. Do you think that going forward, you will feel more confident making decisions when it comes to PrEP?

End of Interview

This is the end of the interview today. Before we wrap up, is there anything else you would like to share with me? Thank you for your time.